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Gabalawy, 2011). The cells in the synovium can produce several 
pro-inflammatory cytokines and matrix-degrading enzymes. At 
the interface of the synovium, cartilage and bone, pannus tissue 
is formed, which contributes to bone destruction. An import-
ant mediator of these processes is tumor necrosis factor alpha 
(TNF-α) (Vasanthi et al., 2007). Specific inhibitors of TNF-α are 
the most widely used biological therapeutics and can successful-
ly inhibit the progress of RA in the majority of patients (Mewar 
and Wilson, 2011).
Synovial pathology is also described for OA. Although OA 
has traditionally been described as a wear-and-tear disease of the 
articular cartilage, synovitis is observed in up to 50% of the OA 
patients and may contribute to the disease process (Scanzello and 
Goldring, 2012). A second factor that contributes to the synovi-
al thickening in OA is tissue fibrosis (Wenham and Conaghan, 
2010). Synovial fibrosis is also associated with joint pain and 
stiffness (Remst et al., 2015). Although the pathogenesis of OA 
1  Introduction
Rheumatoid arthritis (RA) and osteoarthritis (OA) are the most 
common rheumatic diseases. The global incidence of RA is 
estimated to be 0.5%-1% (Gabriel and Michaud, 2009) and an 
estimated 12.1% of the adult population has clinical symptoms 
of OA (Lawrence et al., 2008). RA and OA are both viewed as 
multi-factorial diseases involving multiple risk factors (Ala-
manos and Drosos, 2005; Blagojevic et al., 2010) but their exact 
etiology is unknown. Both diseases cannot be cured at present, 
but disease-modifying drugs (DMARDs) are available for RA 
and non-steroidal anti-inflammatory drugs (NSAIDs) are com-
monly prescribed for OA.
During the abovementioned rheumatic diseases, many pro-
cesses occur in the synovium. Already in the early phase of 
RA, hyperplasia of the synovial lining occurs and immune cells 
infiltrate the sublining (Timmer et al., 2007; Hitchon and El- 
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Abstract
Therapeutic agents that are used by patients with rheumatic and musculoskeletal diseases were originally developed and 
tested in animal models, and although retrospective studies show that these models have limited predictive value, their 
use has continued because of a lack of good in vitro alternatives. In this study, we developed a 3-dimensional synovial 
membrane model made of either human primary synovial cell suspensions or a mix of primary fibroblast-like synoviocytes 
and CD14+ mononuclear cells. We analyzed the composition of the mature micromasses by immunohistochemical 
staining and flow cytometry and showed that the outer surface forms a lining layer consisting of fibroblast-like and 
macrophage-like cells, reflecting the in vivo naïve synovial membrane. To model the affected synovial membrane in rheu-
matoid arthritis (RA), micromasses were exposed to the pro-inflammatory cytokine tumor necrosis factor alpha (TNF-α), 
which led to increased pro-inflammatory cytokine expression and production, and to hyperplasia of the membrane. 
To recreate the synovial membrane in osteoarthritis (OA), the micromasses were exposed to transforming growth factor 
beta (TGF-β), which led to fibrosis-like changes of the membrane, including increased alpha smooth muscle actin 
(α-SMA) and increased expression of fibrosis-related genes PLOD2 and COL1A1. Interestingly, the macrophages in the 
micromasses showed phenotypic plasticity, as prolonged TNF-α or TGF-β stimulation strongly reduced the occurrence of 
CD163+ M2-like macrophages. We show the plasticity of the micromasses as a synovial model for studying RA and OA 
pathology and propose that the synovial lining micromass system can be a good alternative for drug testing.
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2016). This was performed without further isolation and purifi-
cation of the synovial fibroblasts to better represent their cellular 
composition and interactions as present in the starting material. 
In the present study, we further characterize these synovial mi-
cromasses to study the fate of the different cell types. We found 
that after lining formation, the micromass mainly consisted of 
synovial fibroblasts and macrophages. We therefore used micro-
masses produced from primary FLS and macrophages through-
out the rest of the study. Exposure of the synovial micromasses 
to TNF-α or TGF-β was used to mimic the inflammatory con-
ditions present in RA and OA, respectively. We observed that 
short-term exposure to TNF-α already leads to proinflammatory 
gene expression and long-term exposure leads to hyperplasia. 
Long-term exposure to TGF-β resulted in fibrosis-like changes 
of the micromass lining. These results provide a detailed analy-
sis of the synovial micromasses and show their suitability as a 
synovial membrane model for translational research on RA and 
OA. The micromasses may replace animal experiments to study 
synovial pathology. An informal survey done by us among 20 
leading research groups in the arthritis field revealed that 40% 
are of the opinion that in vitro models may replace animal exper-
imentation entirely and 60% find it a useful addition.
2  Materials and methods
Patient material
Synovial biopsies from 5 RA patients were obtained during joint 
replacement surgery from the orthopedics department of the Sint 
Maartenskliniek, Nijmegen, The Netherlands. This material was 
considered surgery surplus material; therefore, its use did not 
need to be approved by an ethical committee. All patients ad-
hered to the American College of Rheumatology (ACR) criteria 
and were end-stage RA. Patients gave written informed consent 
for the use of their material for research. The patient material was 
pseudonymized. Procedures were performed in accordance to the 
code of conduct for responsible use of human tissue in medical 
research1. The presence of a synovial lining was determined on 
7 µm cryosections stained with hematoxylin and eosin (H&E) to 
confirm the synovial origin of the tissue (not shown). 
Human CD14+ cells
Peripheral blood mononuclear cells (PBMCs) were obtained 
from 3 healthy donors by density gradient centrifugation using 
Ficoll-Paque PLUS (GE Healthcare, Chicago, IL, USA). CD14+ 
cells were isolated from the PBMC fraction using the MagniSort 
Human CD14 Positive Selection Kit (Invitrogen, Carlsbad, CA, 
USA) (purity > 90%) according to the manufacturer’s protocol.
Micromass production
Micromasses were produced from either complete synovial cell 
suspensions from RA synovium as described previously (Broeren 
et al., 2016), or from a combination of primary RA fibroblast- 
like synoviocytes (FLS) after several passages and CD14+ mono-
cytes. In short, for micromasses from complete cell suspensions, 
is poorly understood, the cytokine most critically associated with 
processes occurring in OA is transforming growth factor beta 
(TGF-β) (Fang et al., 2016). TGF-β is pivotal for the develop-
ment and maintenance of the articular cartilage, but excessive 
signaling can have detrimental results. For example, adenoviral 
overexpression of TGF-β in mice resulted in osteophyte forma-
tion (Blaney Davidson et al., 2007). Moreover, TGF-β stimulates 
the differentiation of myofibroblasts and the expression of colla-
gen type 1, which contribute to synovial fibrosis (Verrecchia and 
Mauviel, 2007; Remst et al., 2013). 
Many experiments to study the initial stages of inflammation, 
hyperplasia, and fibrosis in the synovium have been performed 
in animal models of RA and OA. However, the predictive value 
of animal models for the screening of potential drugs in RA is 
variable and for OA, many therapies have been successful in 
treating experimental OA, but no treatment has been sufficiently 
effective in clinical trials in humans (Malfait and Little, 2015; 
McNamee et al., 2015). The translation of the animal findings to 
the human synovium is difficult because there is a lack of rele-
vant human in vitro 3D models of synovial pathology, including 
hyperplasia and synovial fibrosis.
Translational arthritis research with human cells is often per-
formed in monolayer culture with in vitro expanded synovial 
fibroblasts. Although monolayer culture with fibroblasts is easy 
to perform, the absence of extracellular matrix and other cell 
types results in alterations of cell functions and a rapid loss of 
phenotype (Zimmermann et al., 2001). One way to maintain the 
cell composition and matrix interactions of the cells is by using 
synovial explants instead of cultured monolayer cells. Although 
synovial explants better represent the original joint environment, 
important disease processes including hyperplasia and cartilage 
damage may have already taken place and can thus not be stud-
ied. Moreover, there is considerable variability between biopsies 
from a single joint, resulting from variations in lining thickness 
(Smith et al., 2003), sublining composition, and an unequal dis-
tribution of synoviocyte types in the synovial membrane (Shiki-
chi et al., 1999; Iwanaga et al., 2000).
To circumvent these challenges and provide a relevant mod-
el for the synovial membrane in which cells can interact with 
cellular matrix, Kiener and co-workers (2006) developed a 
3-dimensional (3D) micromass model based on a mixture of fi-
broblast-like synoviocytes (FLS) and Matrigel® solution. When 
kept on ice, the Matrigel® was liquid and could be mixed with 
cells to obtain a homogenous solution. Single drops were pipet-
ted into a culture well and became solid at 37°C. Within weeks, 
the FLS formed a lining layer on the Matrigel®-medium surface 
that was similar to a synovial membrane (Kiener et al., 2006). 
Reticulin fibers on the surface of the micromasses were arranged 
in an orientation similar to basement membrane structures in 
synovial biopsies. The FLS in the micromass lining produced 
lubricin and showed hyperplasia after 3 weeks of stimulation 
with TNF-α (Kiener et al., 2010). Lining was not formed when 
using dermal fibroblasts.
We recently constructed synovial micromasses using the 
complete cell suspension after biopsy digestion (Broeren et al., 
1 https://www.federa.org/code-goed-gebruik
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(v/v) (Westburg, Leusden, The Netherlands) was added. The 
micromasses were cultured for the time and conditions indicated 
in the results. In general, medium was replaced twice weekly and 
micromasses were cultured at 37°C and 5% CO2.
Flow cytometry
Micromasses were kept on ice for 2 h and the cells were then 
washed to remove the liquified Matrigel®. Unspecific binding 
of antibodies to Fc receptors was blocked by incubation with 
hFc block (1:100 for 20 min at 4°C) (564220 BD Biosciences, 
San Jose, CA, USA). Cells were stained using mouse anti- 
human CD90-APC (1:20 for 30 min at 4°C), mouse anti-hu-
man CD68-PE (1:20 for 60 min at 4°C) and mouse anti-human 
CD14-APC (1:20 for 60 min at 4°C). The samples were mea-
sured on the CyAn ADP analyzer (Beckman Coulter, Woerden, 
The Netherlands) using an 488 nm laser in the FL7 and FL8 
channels for Alexa Fluor 568/PE and APC, respectively. Gates 
were determined using fluorescence minus one (FMO). The 
gating strategy and unstained controls are shown in Figure S12. 
the biopsies were digested using Liberase™ (Roche, Basel, 
Switzerland) for 1 h at 37°C and the cells were filtered through 
a 70 µm cell strainer (Corning, NY, USA). Red blood cells 
(RBCs) were lysed for 2 min at room temperature (RT) in 
4 ml RBC lysis buffer (155 nM NH4Cl, 12 mM KHCO3, 
0.1 mM EDTA, pH 7.3). The cells were mixed on ice with liq-
uid Matrigel® and 25 µl droplets containing 5x105 cells were 
pipetted on a poly-(2-hydroxyethyl methacrylate) (poly-HEMA) 
(Sigma-Aldrich, Zwijndrecht, The Netherlands) coated 24-well 
plate (Greiner Bio-one, Alphen a/d Rijn, The Netherlands). 
Alternatively, micromasses were produced from 2x105 FLS 
combined with 106 CD14+ mononuclear cells. FLS were ob-
tained after biopsy digestion and RBC lysis by culturing the 
adhering cell fraction and passaging the cells at least once. After 
30 min gelation at 37°C, 500 µl Roswell Park Memorial Institute 
(RPMI) medium (Gibco, Thermofisher Scientific, Waltham, MA, 
USA) supplemented with 10% heat-inactivated fetal calf serum 
(FCS) (v/v) (Gibco, Thermofischer Scientific), 1 mM pyruvate 
(Thermofisher Scientific) and 1% penicillin/streptomycin (P/S) 
2 doi:10.14573/altex.1804161s
Tab. 1: List of antibodies
Antibody Isotype Conjugate Monoclonal/ Stock Dilution Appli- Company Catalog 
   Polyclonal concentration  cation  number
CD14 Mouse IgG2a, κ APC Monoclonal [M5E2] 200 µg/ml 1:20 FC Biolegend 301808
CD68 Mouse IgG2b, κ PE Monoclonal [Y1/82A] 100 µg/ml 1:20 FC eBioscience  12-0689
CD90 Mouse IgG1, κ APC Monoclonal [5E10] 50 µg/ml 1:20 FC eBioscience 17-0909
11-Fibrau Mouse IgG2a N/A Monoclonal [D7-FIB] 1 mg/ml 1:100 IHC AbD Serotec MCA1399G
α-SMA Rabbit IgG N/A Polyclonal 0.2 mg/ml 1:400 IHC Abcam ab5694
CD3 Mouse IgG1, κ N/A Monoclonal [F7.2.38] Undetermined 1:50 IHC DAKO M7254
CD20 Mouse IgG2a, κ N/A Monoclonal [L26] 18 µg/ml 1:100 IHC Cell Marque 120M-84
CD31 Rabbit IgG N/A Unspecified 100 µg/ml 1:50 IHC Genetex GTX48364
CD68 Mouse IgG1, κ N/A Monoclonal [KP1] 410 µg/ml 1:100 IHC DAKO M0814
CD163 Mouse IgG1 N/A Monoclonal [10D6] Undetermined 1:25 IHC Thermo MA5-11458 
       Fischer 
Ki67 Rabbit IgG N/A Monoclonal [SP6] Undetermined 1:100 IHC Thermo  RM-9106 
       Fischer 
Mouse IgG1, κ  N/A N/A N/A 100 µg/ml * IHC DAKO X0931
Mouse IgG2a, κ N/A N/A N/A 100 µg/ml * IHC DAKO X0943
Rabbit IgG  N/A N/A N/A 15 mg/ml * IHC DAKO X0936
Anti-mouse N/A HRP N/A 1.3 mg/ml 1:200 IHC DAKO P0260 
IgA/G/M
Anti-mouse N/A Biotinylated N/A 0.5 mg/ml 1:200 IHC Vector BA-2001 
IgG       Laboratories 
Anti-rabbit IgG N/A Biotinylated N/A 1.5 mg/ml 1:400 IHC Vector PK 6101 
       Laboratories 
APC, allophycocyanin; FC; flow cytometry, HRP; horseradish peroxidase, IHC, immunohistochemistry; N/A, not applicable; PE, phycoerythrin 
* Similar concentration (not dilution) to primary antibody directed to antigen of interest.
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hyperplasia, Ki67, and fibrosis analysis, 3 sections were analyzed 
per micromass and per section up to 5 pictures were taken of the 
micromass lining after H&E-staining, Ki67 staining, or α-SMA 
staining, respectively. For CD163 analysis, pictures were taken 
of the complete micromass matrix. Images were analyzed using 
Leica Application Suite (LAS) software. 
Gene expression analysis
The micromasses were dissolved in 500 µl Tri reagent (Sig-
ma-Aldrich) and total RNA was isolated according to the 
manufacturer’s protocol. qPCR was performed as previously 
described (Vermeij et al., 2015). Primer sequences are listed in 
Table 2. Values are depicted as threshold cycle, corrected for 
GAPDH expression.                              
Multiplex ELISA
Cytokines and chemokines in supernatants were measured on a 
Bio-Plex 200 system using a magnetic bead-based multiplex im-
munoassay. Data analysis was performed with Bio-Plex manager 
software (both Bio-Rad). 
Statistical analysis
The results are displayed as box plot (median) with whiskers: 
min to max. Statistical analysis was performed by Mann- 
Whitney U test using GraphPad Prism software v5.03. P-values 
below 0.05 were regarded as significant.
3  Results
3.1  Analysis of micromass composition      
and formation
The composition of the cell suspension after digestion of a 
synovial biopsy was determined using cell surface markers. In 
the cell suspension prior to micromass formation, we observed 
cells positive for fibroblast marker CD90 (67.6%), monocyte/
macrophage marker CD68 (23.1%), and monocyte marker CD14 
(CD14low 22.9% and CD14high 4.58%) (Fig. 1A, Fig. S12). This 
cell composition was comparable in independent replicates. No 
A comprehensive overview of all antibodies used in this study 
is shown in Table 1.
Immunohistochemistry
Micromasses were fixed in 2% paraformaldehyde in phos-
phate-buffered saline (PBS)/1 mM CaCl2 for 2 h, dehydrated and 
embedded in paraffin. 7 µm sections were deparaffinized, 
rehydrated, and stained with H&E or processed for immuno-
histochemistry. For immunohistochemistry, endogenous perox-
idase activity was blocked with 3% H2O2 (Merck Millipore, 
Amsterdam, The Netherlands) in methanol and antigen re-
trieval was performed in 10 mM citrate buffer, pH 6.0 at 60°C. 
Subsequently, sections were stained with primary antibodies: 
mouse anti-human 11-Fibrau (1:100 for 60 min at RT), mouse 
anti-human CD68 (1:100 for 60 min at RT), mouse anti- 
human CD163 (1:25 for 60 min at RT), rabbit anti-human 
alpha smooth muscle actin (α-SMA) (1:400 overnight at 4°C), 
or rabbit anti-human Ki67 (1:100 for 60 min at RT). Isotype 
control antibodies were used at the same concentrations as the 
primary antibodies. Subsequently, the primary antibodies for 
CD68 were stained with HRP-conjugated rabbit anti-mouse 
IgA/G/M (1:200 for 60 min at RT), antibodies for 11-Fibrau 
and CD163 were stained with biotinylated anti-mouse IgG H+L 
(1:100 for 30 min at RT), and antibodies for α-SMA and Ki67 
were stained with biotinylated anti-rabbit (1:400 for 30 min at 
RT). For 11-Fibrau, CD163, and α-SMA, a biotin-streptavidin 
detection system was used according to the manufacturer’s 
protocol (Vector Laboratories). Peroxidase was developed with 
diaminobenzidine and counterstained with hematoxylin for 
60 sec. Representative pictures of all control IgGs are shown in 
Figure S32. A comprehensive overview of all antibodies used in 
this study is shown in Table 1.
Image analysis
Microscopic images for histology were taken using the VS120 
slide scanner (Olympus, Leiderdorp, The Netherlands) using 
Panoramic Viewer (3DHISTECH, Budapest, Hungary) and for 
quantification pictures were taken using the Leica DMR light 
microscope after randomization and blinding of the samples. For 
Tab. 2: Primer sequences
Gene Forward primer sequence Reverse primer sequence
ACTA2 CTGACCCTGAAGTACCCGATA GAGTGGTGCCAGATCTTTTCC
COL1A1 AGATCGAGAACATCCGGAG AGTACTCTCCACTCTTCCAG
GAPDH ATCTTCTTTTGCGTCGCCAG TTCCCCATGGTGTCTGAGC
IL1B TGGGTAATTTTTGGGATCTACACTCT AATCTGTACCTGTCCTGCGTGTT
IL6 AGCCCACCGGGAACGA GGACCGAAGGCGCTTGT
IL8 AGAAGTTTTTGAAGAGGGCTGAGA CAGACCCACACAATACATGAAGTG
PLOD2 AAGACTCCCCTACTCCGGAAA AGCAGTGGATAATAGCCTTCCAA
SERPINE1 GTCTGCTGTGCACCATCCCCCATC TTGTCATCAATCTTGAATCCCATA
TNF TCTTCTCGAACCCCGAGTGA CCTCTGATGGCACCACCAG
Broeren et al.
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These results show that the mixed cell population is maintained 
during micromass culture. The CD14high fraction dropped to 
3.38% and the CD14low fraction was not detected on day 7. The 
distinct CD68+/CD14low cells had lost most CD14 expression 
after 7 days.
The kinetics of lining formation and cell migration in the syno-
vial micromasses were assessed at different time points. Immedi-
ately after micromass formation, the cells had not regained their 
original morphology and all cells were round-shaped (Fig. 1B). 
T cells (CD3), B cells (CD20), or dendritic cells (CD11c) were 
observed in the cell suspension (data not shown). Almost all 
CD68+ cells were also CD14low.
We next analyzed the composition of the mature micromass de-
veloped from the synovial cell suspension after formation of the 
lining on day 7. The composition of the micromass was simi-
lar to the cultured cell suspension at day 0 (Fig. 1A, Fig. S12). 
We observed cells positive for CD90 (62.0%) and CD68 (30.8%). 
The CD68+ cells were also CD14low, as in the cell suspension. 
Fig. 1: Flow cytometry and 
histological analysis of 
synovial cell suspension and 
micromasses 
(A) A RA synovial biopsy was 
digested using Liberase™.  
Cells were cultured for  
< 24 hours (Fig. 1A, day 0) 
or mixed with Matrigel® and 
cultured for 7 days, after which 
the Matrigel® was re-liquified 
on ice (Fig. 1A, day 7). The cell 
suspensions were subsequently 
stained for fibroblasts (CD90), 
macrophages (CD68), and 
monocytes (CD14). Similar 
profiles were obtained in at 
least 3 experiments with unique 
donors. FS, forward scatter;  
SS, side scatter. The gating 
strategy and unstained controls 
are shown in Fig. S12.  
(B) Micromasses were fixed and 
embedded in paraffin at different 
time points (day 0, 4, 5, 7, 14, 
and 35). 7 µm sections were 
stained with H&E, anti-CD68, 
or antibodies against fibroblast 
marker 11-Fibrau. Pictures were 
taken at 200x magnification. 
Negative control IgG stainings 
are shown in Fig. S32.
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Based on the observation that the synovial fibroblasts and 
macrophages were the two cell types that we could identify 
in the lining of micromasses composed of synovial cell suspen-
sions and because these cells represent the two types of synov-
iocytes found in the synovial lining, we switched in subsequent 
experiments to micromasses produced from cultured primary 
RA FLS and primary CD14+ cells purified from peripheral 
blood of healthy donors. This approach has previously been ex-
plored by Kiener et al. (2006). As expected, these micromasses 
produced a lining in 7 days (Fig. 2A), which contained both 11- 
Fibrau+ FLS and CD68+ macrophages (Fig. 2B,C).     
3.2  Long-term exposure of synovial micromasses 
to inflammatory stimuli leads to inflammatory 
gene  expression and cytokine production
We established the inflammatory response of micromasses to 
3-week stimulation with 10 ng/ml recombinant human TNF-α 
(Abcam, Cambridge, UK) or TGF-β (Biolegend, San Diego, CA, 
USA), which was replenished twice per week. On gene expres-
sion level, we observed a significant increase in expression of IL6 
and IL8 with both stimuli (Fig. 3A). TNF and IL1B expression 
were not significantly increased. On protein level, IL-6 levels 
in the micromass supernatants were increased after stimulation 
The first time point at which a distinct lining was visible was af-
ter 7 days. In multiple experiments we observed lining formation 
between day 7 and day 14. The synovial lining remained visible 
until the end of the experiment at day 35. Immediately after 
formation of the micromasses, CD68+ cells appeared randomly 
distributed over the complete micromass. During the first week 
of micromass culture, a gradual increase in the relative number 
of CD68+ cells was observed and after 7 days most CD68+ cells 
appeared as large cells. Throughout the 35 days of culture, many 
11-Fibrau+ fibroblasts were present at all time points. The ana-
lyzed biopsy also contained CD31+ endothelial cells and foci of 
B cells (CD20+) and T cells (CD3+), which incorporated at low 
frequency in the micromasses. However, these cells had disap-
peared by day 7 (Fig. S22). 
Fig. 2: Composition of micromasses constructed from primary 
RA FLS and CD14+ PBMCs 
(A) H&E staining of day 7 micromasses at 50x and 200x 
magnification. (B) CD68 staining of macrophages in the micromass. 
Black arrows indicate CD68+ cells and grey arrows indicate  
CD68-negative cells. (C) 11-Fibrau staining of FLS in the 
micromass. Black arrows indicate 11-Fibrau+ cells and grey arrows 
indicate 11-Fibrau-negative cells. Negative control IgG staining is 
shown in Fig. S32.
Fig. 3: Gene expression after short-term micromass  
exposure to inflammatory stimuli
Micromasses were generated from primary RA FLS and CD14+ 
PBMCs and stimulated for 3 weeks with 10 ng/ml recombinant 
human TNF-α or TGF-β, which was replenished twice per week. 
Control micromasses received culture medium without stimulation. 
(A) The gene expression of pro-inflammatory cytokines IL1B, IL6, 
IL8, and TNF was measured by qPCR. Gene expression values 
were corrected for GAPDH expression and are depicted as ΔCt.  
(B) Cytokine secretion was measured in the culture supernatant 
using a multiplex ELISA. n = 5/6 per group. Data points are 
combined from 2 independent experiments. Expression levels were 
compared to medium control by Mann-Whitney U test. *, p < 0.05; 
**, p < 0.01; ***, p < 0.001.
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the complete micromass showed a hypertrophic phenotype (Fig. 
4A). After stimulation with TNF-α, there was a strong reduction 
in cells displaying this phenotype and instead cells showed a 
spindle-like morphology. The large, round cells were positive-
ly stained for CD163, a membrane marker associated with type 
2 macrophages (Fig. 4B) (Kowal et al., 2011). These cells, which 
were distributed throughout the complete micromass, disap-
peared upon TNF-α or TGF-β stimulation (Fig. 4E).
An additional important feature of arthritis is synovial hyper-
plasia, which was also assessed after 3 weeks of repeated stim-
ulation. Without TNF-α stimulation, the lining was on average 
1 cell layer thick (Fig. 4C). After long-term stimulation with 
with both TNF-α and TGF-β (Fig. 3B). IL-8 was only increased 
after stimulation with TNF-α, and TGF-β stimulation induced 
the release of TNF-α from the micromasses. These results show 
that the micromasses are sensitive to inflammatory triggers.                 
3.3  Long-term exposure of synovial micromasses 
to TNF-α leads to hyperplasia of the micromass 
lining and an altered macrophage phenotype
In addition to pro-inflammatory effects, we observed striking 
differences in the cells residing in the micromass matrix after 
long-term stimulation with TNF-α. When the micromasses were 
not treated with TNF-α, some CD68+ cells distributed throughout 
Fig. 4: Micromass lining 
hyperplasia and macrophage 
phenotype after long-term 
stimulation
Micromasses were generated 
from primary RA FLS and CD14+ 
PBMCs and stimulated for  
3 weeks with 10 ng/ml re-
combinant human TNF-α or 
TGF-β, which was replenished 
twice per week. Control 
micromasses received culture 
medium without stimulation. 
Micromasses were stained for 
CD68 (A), CD163 (B) with  
H&E (C) and Ki67 (D). Black 
arrows indicate cells positive 
for the marker of interest. Grey 
arrows indicate a hyperplasic 
lining. (E) Quantification of 
CD163+ cells throughout the 
entire micromass. Values were 
corrected for the total surface 
area of the images analyzed 
and are depicted as fold change 
compared to the average of  
the unstimulated controls.  
(F) Quantification of H&E staining 
for lining hyperplasia.  
(G) Quantification of Ki67 staining 
for proliferation of the micromass 
lining. n = 5/6 per group and the 
average score of > 3 images per  
3 sections of every micromass 
was calculated. Statistical 
analysis was performed by 
Mann-Whitney U test comparing 
to medium condition. *, p < 0.05; 
**, p < 0.01. Negative control IgG 
staining is shown in Fig. S32.
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1996). However, after prolonged culture the disease imprint is 
gradually lost (Zimmermann et al., 2001; Hirth et al., 2002; Har-
dy et al., 2013), making the FLS more suitable for the micromass 
model in which part of the disease is mimicked by stimulation 
with TNF-α or TGF-β. The micromass model is therefore not 
dependent on the original disease phenotype of the fibroblasts. 
This fits with the observation that no spontaneous hyperplasia 
was observed without stimulation with exogenous TNF-α.
The survival of FLS and macrophage-like cells was observed 
both by immunohistochemistry and flow cytometry. Several 
results indicate changes in the macrophage population. During 
micromass culture, the number of CD68+ cells expressing CD14 
TNF-α, the lining thickness increased. The hyperplasia was as-
sessed by quantifying the amount of hematoxylin staining and by 
the expression of the proliferation marker Ki67 in the lining in 
> 9 images per micromass. The cellularity and proliferation of the 
lining was significantly increased after TNF-α stimulation (Fig. 
4D,F,G) whereas this was unaltered upon TGF-β stimulation.
3.4  TGF-β can induce fibrosis-like 
changes in the micromass lining
The effects of the 3-week stimulation on micromass fibrosis-as-
sociated processes were first assessed on the gene expression 
level. TGF-β signaling marker SERPINE1 was significantly 
induced by recombinant TGF-β, indicating that active TGF-β 
signaling was induced in the micromasses (Fig. 5A). This result-
ed in an increased expression of PLOD2, Alpha Smooth Muscle 
Actin (ACTA2), and collagen type 1 (COL1A1), which are all 
associated with fibrosis (Remst et al., 2014). Histological stain-
ing of α-SMA showed that fibrotic-like changes had occurred 
in the micromass lining, which was significantly increased after 
stimulation with TGF-β (Fig. 5B,C). Moreover, TGF-β induced 
a stellate cell morphology of α-SMA+ cells, characteristic for 
myofibroblasts (Fig. 5B) (Bagalad et al., 2017).
4  Discussion
In this study, we further characterized the 3D synovial micromass 
model produced from primary human biopsies for application 
in both RA and OA research as an alternative to animal exper-
iments. The model was first explored by Kiener and co-work-
ers (2006) based on primary synovial fibroblast (FLS) culture. 
Those experiments were focused on cell-cell and cell-matrix 
interactions during the formation of the lining and the involve-
ment of Cadherin-11 (Kiener et al., 2006; Lee et al., 2007). We 
adapted a procedure that was briefly explored in these studies 
to produce micromasses with both FLS and CD14+ PBMCs, 
which resulted in a lining that included 11-Fibrau+ fibroblasts 
and CD68+ macrophages (Kiener et al., 2010). These two cell 
types were the predominant lining cell types in the micromasses 
produced from the complete synovial cell suspension and cor-
respond with the cell types observed in the intimal layer of the 
synovium, the type B synoviocyte (FLS) and type A synoviocyte 
(macrophage-like synoviocyte), respectively (Smith, 2011). The 
survival of the macrophage-like cells has previously been shown 
to be dependent on the presence of synovial fibroblasts (Kiener 
et al., 2010). The inclusion of these cells in the micromass model 
is important, because the macrophages produce large amounts 
of TNF-α and TGF-β and can activate latent TGF-β (Wahl et al., 
1990; Kinne et al., 2000). Moreover, macrophages are involved 
in bone erosion, cartilage damage, and ectopic bone formation in 
RA and OA (Goldring and Gravallese, 2000; Blom et al., 2004; 
Bondeson et al., 2006).
For the micromasses that were generated from primary CD14+ 
PBMCs and primary FLS, FLS had first been cultured in vitro. It 
has been observed that directly after digestion of the synovium, 
the FLS have a disease phenotype, which includes the sponta-
neous production of pro-inflammatory cytokines (Firestein, 
Fig. 5: Fibrosis-like changes after long-term stimulation  
of micromasses 
Micromasses were generated from primary RA FLS and CD14+ 
PBMCs and stimulated for 3 weeks with 10 ng/ml recombinant 
human TNF-α or TGF-β, which was replenished twice per week. 
Control micromasses received culture medium without stimulation. 
(A) qPCR analysis of downstream TGF-β signaling genes and 
fibrosis-related genes. Gene expression values were corrected 
for GAPDH expression and are depicted as ΔCt. (B) Staining 
of α-SMA in the micromasses. Magnification 200x. (C) Digital 
quantification of α-SMA+ lining surface. Values are depicted as 
fold change compared to unstimulated micromasses. n = 5/6 per 
group. Statistical analysis was performed by Mann-Whitney U test 
comparing to medium condition. *, p < 0.05; **, p < 0.01. Negative 
control IgG staining is shown in Fig. S32.
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interactions and several in vitro studies have aimed at recreating 
3D matrix mixed with specific cells. For example, chondrocytes 
can be co-suspended with gelatin microspheres in an alginate 
solution to obtain an articular cartilage-like structure (Su et al., 
2012). This can be cultured in combination with FLS and in vi-
tro differentiated macrophages to mimic OA cartilage pathology 
(Peck et al., 2018). In addition, FLS have been cultured in sev-
eral scaffolds to generate 3D structures. In one study, FLS were 
combined with endothelial cells in a methylcellulose sphere that 
was subsequently incorporated in a collagen gel (Maracle et al., 
2017). This method was used to study angiogenesis into a col-
lagen scaffold. These studies highlight the added value of 3D 
models for joint tissues and the micromass adds a model to study 
the synovial membrane.
We propose that the synovial micromass model can be a solu-
tion for experiments that require a synovial membrane in which 
disease processes have not yet occurred, since the availability 
of healthy synovial tissue is very limited. The production of mi-
cromasses will result in a uniform composition of the starting 
material, which can also be easily manipulated with regard to 
its composition. In future applications, the micromasses may be 
co-cultured with different cell types or scaffolds, or in co-cul-
ture with cartilage explants to study effects on cartilage degen-
eration. Although no 3D models that include all cell types and 
tissues involved are available yet, the micromass model can be 
a good alternative to animal experiments studying RA and OA 
for fundamental research, target validation, as well as pre-clin-
ical treatment testing. To our knowledge, this is the first human 
3D culture model to study the interplay between macrophages 
and fibroblast-like synoviocytes in hyperplasia and synovial 
fibrosis-like pathology by stimulation with TNF-α and TGF-β, 
respectively.
References
Alamanos, Y. and Drosos, A. A. (2005). Epidemiology of 
adult rheumatoid arthritis. Autoimmun Rev 4, 130-136. 
doi:10.1016/j.autrev.2004.09.002
Bagalad, B. S., Mohan Kumar, K. P. and Puneeth, H. K. (2017). 
Myofibroblasts: Master of disguise. J Oral Maxillofac Pathol 
21, 462-463. doi:10.4103/jomfp.JOMFP_146_15
Blagojevic, M., Jinks, C., Jeffery, A. and Jordan, K. P. (2010). 
Risk factors for onset of osteoarthritis of the knee in older 
adults: A systematic review and meta-analysis. Osteoarthritis 
Cartilage 18, 24-33. doi:10.1016/j.joca.2009.08.010
Blaney Davidson, E. N., Vitters, E. L., van Beuningen, H. M. 
et al. (2007). Resemblance of osteophytes in experimental 
osteoarthritis to transforming growth factor beta-induced 
osteophytes: Limited role of bone morphogenetic protein in 
early osteoarthritic osteophyte formation. Arthritis Rheum 56, 
4065-4073. doi:10.1002/art.23034
Blom, A. B., van Lent, P. L., Holthuysen, A. E. et al. (2004). 
Synovial lining macrophages mediate osteophyte formation 
during experimental osteoarthritis. Osteoarthritis Cartilage 
12, 627-635. doi:10.1016/j.joca.2004.03.003
Bondeson, J., Wainwright, S. D., Lauder, S. et al. (2006). The 
role of synovial macrophages and macrophage-produced cyto-
decreased at day 7 compared to day 0. This can be the result of 
macrophage differentiation, which is associated with a decrease 
in CD14 expression (Ohradanova-Repic et al., 2016). During 
the 3-week micromass culture, we observed large CD68+ and 
CD163+ cells. These cells represent an M2-like anti-inflammato-
ry macrophage phenotype (Vandooren et al., 2009; Kowal et al., 
2011). They disappeared upon stimulation with TNF-α, which is 
known to polarize macrophages to a pro-inflammatory M1-like 
phenotype (Kennedy et al., 2011). We also observed significant 
down-regulation of CD163 by TGF-β, which has also been de-
scribed previously (Pioli et al., 2004). Although additional mark-
ers are required for more accurate and reliable identification of 
specific cell types and cell subsets, the results clearly indicate 
plasticity of the macrophage-like cell population in the synovial 
micromass.
Interestingly, we found that when put on ice, the Matrigel® liq-
uidized and could be washed away from the cells. The resulting 
cell suspension could be analyzed by flow cytometry without the 
requirement of enzymatic digestion, which further enhances the 
applicability of the micromass model.
We evaluated the long-term effects of TNF-α exposure on 
micromasses. In addition to the well-known role of TNF-α in 
RA, TNF-α produced by the osteoarthritic synovium is strongly 
associated with systemic low-grade inflammation and produc-
tion of matrix-degrading enzymes by multiple cells in the joint 
(Bondeson et al., 2006; Ozler et al., 2016). The observation 
that systemic TNF-α levels are increased prior to the most pro-
nounced cartilage damage supports the hypothesis that inflam-
mation in OA is a cause rather than a symptom. We observed 
that the pro-inflammatory effects of TNF-α can be studied in 
the micromasses. In addition, synovial hyperplasia is observed 
in the synovium of both RA and OA patients (Bondeson et al., 
2010). We could re-create this pathogenic process by stimulating 
the micromasses for 3 weeks with TNF-α, which is a major ad-
vantage compared to studies using synovial biopsies, in which 
hyperplasia has already occurred (Izquierdo et al., 2011).
Although both pro- and anti-inflammatory functions of TGF-β 
have been described for arthritic diseases, we observed a strong 
increase in expression of IL-6 and TNF-α after stimulation with 
TGF-β. IL-8 mRNA but not protein was significantly increased 
by TGF-β. The effects of TGF-β on IL-6 and IL-8 have been 
described before in PBMCs and synovial fibroblasts (Turner et 
al., 1990; Cheon et al., 2002). Interestingly, TGF-β stimulation 
resulted in increased TNF-α secretion, but an increase of mRNA 
level was not observed. Previous experiments with TGF-β and 
synovial cell cultures did not result in increased TNF-α produc-
tion, which indicates that our finding of increased TNF-α might 
be an indirect effect (Brennan et al., 1990). The most pronounced 
effect of long-term TGF-β stimulation was the strong increase 
of an α-SMA+ lining, which was not observed after stimulation 
with TNF-α. The increased α-SMA was not caused by hyperpla-
sia, which did not occur after TGF-β stimulation. 
The joint is considered a complex organ and joint diseases like 
RA and OA are thought to involve several cell types and tis-
sues, including the synovium, but also the articular cartilage and 
(subchondral) bone (Mathiessen and Conaghan, 2017). These 
tissues are also dependent on the extracellular matrix for proper 
Broeren et al.
ALTEX 36(1), 2019 27
Kennedy, A., Fearon, U., Veale, D. J. and Godson, C. (2011). 
Macrophages in synovial inflammation. Front Immunol 2, 52. 
doi:10.3389/fimmu.2011.00052
Kiener, H. P., Lee, D. M., Agarwal, S. K. and Brenner, M. B. 
(2006). Cadherin-11 induces rheumatoid arthritis fibro-
blast-like synoviocytes to form lining layers in vitro. Am J 
Pathol 168, 1486-1499. doi:10.2353/ajpath.2006.050999
Kiener, H. P., Watts, G. F., Cui, Y. et al. (2010). Synovial fibro-
blasts self-direct multicellular lining architecture and synthetic 
function in three-dimensional organ culture. Arthritis Rheum 
62, 742-752. doi:10.1002/art.27285
Kinne, R. W., Bräuer, R., Stuhlmüller, B. et al. (2000). Mac-
rophages in rheumatoid arthritis. Arthritis Res 2, 189-202. 
doi:10.1186/ar86
Kowal, K., Silver, R., Slawinska, E. et al. (2011). CD163 and its 
role in inflammation. Folia Histochem Cytobiol 49, 365-374. 
doi:10.5603/FHC.2011.0052
Lawrence, R. C., Felson, D. T., Helmick, C. G. et al. (2008). 
Estimates of the prevalence of arthritis and other rheumatic 
conditions in the United States. Part II. Arthritis Rheum 58, 
26-35. doi:10.1002/art.23176
Lee, D. M., Kiener, H. P., Agarwal, S. K. et al. (2007). Cadher-
in-11 in synovial lining formation and pathology in arthritis. 
Science 315, 1006-1010. doi:10.1126/science.1137306
Malfait, A.-M. and Little, C. B. (2015). On the predictive utility 
of animal models of osteoarthritis. Arthritis Res Ther 17, 225. 
doi:10.1186/s13075-015-0747-6
Maracle, C. X., Kucharzewska, P., Helder, B. et al. (2017). Tar-
geting non-canonical nuclear factor-kappaB signalling atten-
uates neovascularization in a novel 3D model of rheumatoid 
arthritis synovial angiogenesis. Rheumatology (Oxford) 56, 
294-302. doi:10.1093/rheumatology/kew393
Mathiessen, A. and Conaghan, P. G. (2017). Synovitis in osteo-
arthritis: Current understanding with therapeutic implications. 
Arthritis Res Ther 19, 18. doi:10.1186/s13075-017-1229-9
McNamee, K., Williams, R. and Seed, M. (2015). Animal mod-
els of rheumatoid arthritis: How informative are they? Eur J 
Pharmacol 759, 278-286. doi:10.1016/j.ejphar.2015.03.047
Mewar, D. and Wilson, A. G. (2011). Treatment of rheumatoid 
arthritis with tumour necrosis factor inhibitors. Br J Pharma-
col 162, 785-791. doi:10.1111/j.1476-5381.2010.01099.x
Ohradanova-Repic, A., Machacek, C., Fischer, M. B. and Stock-
inger, H. (2016). Differentiation of human monocytes and 
derived subsets of macrophages and dendritic cells by the 
HLDA10 monoclonal antibody panel. Clin Transl Immunolo-
gy 5, e55. doi:10.1038/cti.2015.39
Ozler, K., Aktas, E., Atay, C. et al. (2016). Serum and knee sy-
novial fluid matrixmetalloproteinase-13 and tumor necrosis 
factor-alpha levels in patients with late stage osteoarthritis. 
Acta Orthop Traumatol Turc. doi:10.1016/j.aott.2015.11.003
Peck, Y., Leom, L. T., Low, P. F. P. and Wang, D. A. (2018). 
Establishment of an in vitro three-dimensional model for car-
tilage damage in rheumatoid arthritis. J Tissue Eng Regen Med 
12, e237-e249. doi:10.1002/term.2399
Pioli, P. A., Goonan, K. E., Wardwell, K. and Guyre, P. M. 
(2004). TGF-beta regulation of human macrophage scavenger 
kines in driving aggrecanases, matrix metalloproteinases, and 
other destructive and inflammatory responses in osteoarthritis. 
Arthritis Res Ther 8, R187. doi:10.1186/ar2099
Bondeson, J., Blom, A. B., Wainwright, S. et al. (2010). The 
role of synovial macrophages and macrophage-produced 
mediators in driving inflammatory and destructive responses 
in osteoarthritis. Arthritis Rheum 62, 647-657. doi:10.1002/
art.27290
Brennan, F. M., Chantry, D., Turner, M. et al. (1990). Detection 
of transforming growth factor-beta in rheumatoid arthritis 
synovial tissue: Lack of effect on spontaneous cytokine pro-
duction in joint cell cultures. Clin Exp Immunol 81, 278-285. 
doi:10.1111/j.1365-2249.1990.tb03331.x
Broeren, M. G., de Vries, M., Bennink, M. B. et al. (2016). Sup-
pression of the inflammatory response by disease-inducible 
interleukin-10 gene therapy in a three-dimensional micromass 
model of the human synovial membrane. Arthritis Res Ther 
18, 186. doi:10.1186/s13075-016-1083-1
Cheon, H., Yu, S. J., Yoo, D. H. et al. (2002). Increased expres-
sion of pro-inflammatory cytokines and metalloproteinase-1 
by TGF-β1 in synovial fibroblasts from rheumatoid arthritis 
and normal individuals. Clin Exp Immunol 127, 547-552. 
doi:10.1046/j.1365-2249.2002.01785.x
Fang, J., Xu, L., Li, Y. and Zhao, Z. (2016). Roles of TGF-beta 
1 signaling in the development of osteoarthritis. Histol Histo-
pathol 31, 1161-1167. doi:10.14670/hh-11-779 
Firestein, G. S. (1996). Invasive fibroblast-like synoviocytes 
in rheumatoid arthritis. Passive responders or transformed 
aggressors? Arthritis Rheum 39, 1781-1790. doi:10.1002/
art.1780391103
Gabriel, S. E. and Michaud, K. (2009). Epidemiological studies 
in incidence, prevalence, mortality, and comorbidity of the 
rheumatic diseases. Arthritis Res Ther 11, 229. doi:10.1186/
ar2669
Goldring, S. R. and Gravallese, E. M. (2000). Pathogenesis of 
bone erosions in rheumatoid arthritis. Curr Opin Rheumatol 
12, 195-199. doi:10.1097/00002281-200005000-00006
Hardy, R. S., Hülso, C., Liu, Y. et al. (2013). Characterisation 
of fibroblast-like synoviocytes from a murine model of joint 
inflammation. Arthritis Res Ther 15, R24-R24. doi:10.1186/
ar4158
Hirth, A., Skapenko, A., Kinne, R. W. et al. (2002). Cytokine 
mRNA and protein expression in primary-culture and repeat-
ed-passage synovial fibroblasts from patients with rheumatoid 
arthritis. Arthritis Res 4, 117-125. doi:10.1186/ar391
Hitchon, C. A. and El-Gabalawy, H. S. (2011). The synovi-
um in rheumatoid arthritis. Open Rheumatol J 5, 107-114. 
doi:10.2174/1874312901105010107
Iwanaga, T., Shikichi, M., Kitamura, H. et al. (2000). Morphol-
ogy and functional roles of synoviocytes in the joint. Arch 
Histol Cytol 63, 17-31. doi:10.1679/aohc.63.17
Izquierdo, E., Canete, J. D., Celis, R. et al. (2011). Synovial 
fibroblast hyperplasia in rheumatoid arthritis: Clinicopatho-
logic correlations and partial reversal by anti-tumor necrosis 
factor therapy. Arthritis Rheum 63, 2575-2583. doi:10.1002/
art.30433
Broeren et al.
ALTEX 36(1), 2019 28
Vandooren, B., Noordenbos, T., Ambarus, C. et al. (2009). Ab-
sence of a classically activated macrophage cytokine signature 
in peripheral spondylarthritis, including psoriatic arthritis. Ar-
thritis Rheum 60, 966-975. doi:10.1002/art.24406
Vasanthi, P., Nalini, G. and Rajasekhar, G. (2007). Role of 
tumor necrosis factor-alpha in rheumatoid arthritis: A re-
view. APLAR J Rheumatol 10, 270-274. doi:10.1111/j.1479-
8077.2007.00305.x
Vermeij, E. A., Broeren, M. G., Bennink, M. B. et al. (2015). 
Disease-regulated local IL-10 gene therapy diminishes sy-
novitis and cartilage proteoglycan depletion in experimental 
arthritis. Ann Rheum Dis 74, 2084-2091. doi:10.1136/ann-
rheumdis-2014-205223
Verrecchia, F. and Mauviel, A. (2007). Transforming growth 
factor-β and fibrosis. World J Gastroenterol 13, 3056-3062. 
doi:10.3748/wjg.v13.i22.3056
Wahl, S. M., Allen, J. B., Wong, H. L. et al. (1990). Antagonistic 
and agonistic effects of transforming growth factor-beta and 
IL-1 in rheumatoid synovium. J Immunol 145, 2514-2519. 
Wenham, C. Y. and Conaghan, P. G. (2010). The role of synovi-
tis in osteoarthritis. Ther Adv Musculoskelet Dis 2, 349-359. 
doi:10.1177/1759720X10378373
Zimmermann, T., Kunisch, E., Pfeiffer, R. et al. (2001). Iso-
lation and characterization of rheumatoid arthritis synovial 
fibroblasts from primary culture – Primary culture cells mark-
edly differ from fourth-passage cells. Arthritis Res 3, 72-76. 
doi:10.1186/ar142
Conflict of interest
There are no conflicts of interest to report.
Acknowledgements
We would like to thank Miranda Bennink for her technical sup-
port with flow cytometry and immunohistochemistry and Lynn 
Devilée for her support with the micromass production. The work 
was financially supported by the Dutch Arthritis Foundation 
(grant numbers 11-1-409 and 15-2-403) and ZonMw program 
“more research with less animals” (114021001).
receptor CD163 is Smad3-dependent. J Leukoc Biol 76, 500-
508. doi:10.1189/jlb.1203617
Remst, D. F., Blaney Davidson, E. N., Vitters, E. L. et al. (2013). 
Osteoarthritis-related fibrosis is associated with both elevated 
pyridinoline cross-link formation and lysyl hydroxylase 2b ex-
pression. Osteoarthritis Cartilage 21, 157-164. doi:10.1016/j.
joca.2012.10.002
Remst, D. F., Blom, A. B., Vitters, E. L. et al. (2014). Gene 
expression analysis of murine and human osteoarthritis sy-
novium reveals elevation of transforming growth factor be-
ta-responsive genes in osteoarthritis-related fibrosis. Arthritis 
Rheumatol 66, 647-656. doi:10.1002/art.38266
Remst, D. F., Blaney Davidson, E. N. and van der Kraan, P. M. 
(2015). Unravelling osteoarthritis-related synovial fibrosis: A 
step closer to solving joint stiffness. Rheumatology (Oxford) 
54, 1954-1963. doi:10.1093/rheumatology/kev228
Scanzello, C. R. and Goldring, S. R. (2012). The role of sy-
novitis in osteoarthritis pathogenesis. Bone 51, 249-257. 
doi:10.1016/j.bone.2012.02.012
Shikichi, M., Kitamura, H. P., Yanase, H. et al. (1999). Three-di-
mensional ultrastructure of synoviocytes in the horse joint as 
revealed by the scanning electron microscope. Arch Histol 
Cytol 62, 219-229. doi:10.1679/aohc.62.219
Smith, M. D., Barg, E., Weedon, H. et al. (2003). Microarchi-
tecture and protective mechanisms in synovial tissue from 
clinically and arthroscopically normal knee joints. Ann Rheum 
Dis 62, 303-307. doi:10.1136/ard.62.4.303
Smith, M. D. (2011). The normal synovium. Open Rheumatol J 
5, 100-106. doi:10.2174/1874312901105010100
Su, K., Lau, T. T., Leong, W. et al. (2012). Creating a living hy-
aline cartilage graft free from non-cartilaginous constituents: 
An intermediate role of a biomaterial scaffold. Adv Funct Ma-
ter 22, 972-978. doi:10.1002/adfm.201102884
Timmer, T. C., Baltus, B., Vondenhoff, M. et al. (2007). In-
flammation and ectopic lymphoid structures in rheumatoid 
arthritis synovial tissues dissected by genomics technology: 
Identification of the interleukin-7 signaling pathway in tissues 
with lymphoid neogenesis. Arthritis Rheum 56, 2492-2502. 
doi:10.1002/art.22748
Turner, M., Chantry, D. and Feldmann, M. (1990). Transforming 
growth factor beta induces the production of interleukin 6 by 
human peripheral blood mononuclear cells. Cytokine 2, 211-
216. doi:10.1016/1043-4666(90)90018-O
